A community update on our groundbreaking research to support ISB science.
Reimagine:
Brain Health
Donate
Event Details
Our 2020 virtual Reimagine event highlighted ISB’s cutting-edge brain health research and our unique approach to studying and treating Alzheimer’s and other diseases. Specifically, we featured some of our latest findings, the promise of multimodal therapies to slow and even reverse dementia, and testimony from caregivers who watched their loved ones succumb to Alzheimer’s disease. Watch the full event online here:
Don't want to miss another event? Subscribe to our newsletter.
Speakers
Our program speakers were Dr. Jim Heath and Dr. Mary Kay Ross, with special appearances by Dr. Lee Hood, Dr. Nathan Price, and more.
Jim Heath, PhD, is President and Professor at ISB. He has received several awards and honors, including the Irving Weinstein Award from the American Association of Cancer Researchers, and the Sackler Prize in the Physical Sciences. He was named one of the top seven innovators in the world by Forbes Magazine, and has founded or cofounded several companies.
Full Speaker Bio
Mary Kay Ross, MD, FACEP
Mary Kay Ross, MD, FACEP, is the founder and CEO of the Seattle-based Brain Health & Research Institute. Prior to launching BHRI, Ross served as Chief Medical Officer of MPI Cognition, the firm credited with introducing multi-modal Alzheimer’s therapies to America.
Full Speaker Bio
Foundation Board
Thank you to our Foundation Board members for making this event possible:
- Douglas Howe, Chairman of the Board
- Electa Anderson
- Marne Anderson
- Laurie Black
- Suzie Burke
- Kathryn Carole Ellison
- Barb Moe
- Chris Moe
The latest innovation:
A multimodal approach
The greatest hope for reversing and preventing Alzheimer's disease and other neurological disorders is a multimodal approach that combines diet, exercise, drug treatment, coaching, brain training and other personalized treatments.
Observational studies suggest this novel approach can slow, stop, and in some cases reverse Alzheimers disease progression. ISB and our partners are conducting clinical trials to put the multimodal approach to rigorous scientific study.
ISB is working to improve the standard of care for Alzheimer's patients.
Thank you to our sponsors!
